Introduction
It is now acknowledged that nitric oxide (NO), formed enzymatically by the action of NO synthase from L-arginine, is a physiologic regulator molecule in various tissues. NO synthase is known to exist in at least three distinct isoforms, i.e., inducible, endothelial, and neuronal1-4). Endothelium-derived NO is a major physiologic regulator of vascular tone in many organs1.2.4. In vitro studies performed in rabbits or rat aortic rings or in isolated perfused rabbit or guinea pig hearts have shown that inhibition of endogenous NO synthesis causes vasoconstriction in these preparations, and that NO is continuously produced in the endothelium5-9). However, whether NO continuously produced in the endothelium of resis- Myocardial work was estimated by the triple product, the product of heart rate, LV systolic pressure and peak LV dP/dt. CVR was calculated as the ratio of mean arterial pressure to mean CBF. 
Discussion

Effects of inhibition of NO synthesis
Our results showed that intracoronary L-NAME, which was associated with doserelated reductions in acetylcholine-induced coronary vasodilation, significantly reduced baseline CBF and increased CVR. The specificity of blockade of NO formation with L-NAME was demonstrated by the findings that D-NAME was ineffective in altering baseline CBF as well as CVR. This indicates that tonic release of NO from the microvasculature under resting conditions contributes to basal coronary microvascular tone, and that at lease 6% of resting coronary microvascular tone is due to NO.
Methodologic considerations
The finding that the flow response to acetylcholine was not completely abolished may be due to incomplete inhibition of NO formation by the dose of L-NAME used in this study, or may suggest that other vasodilating factors are involved in the response to acetylcholine.
The increase in CBF with nitroglycerin, an endothelium-independent vasodilator, before and after L-NAME in a low and high dose was similar, suggesting that the effect of L-NAME on the coronary microvessels is specific for inhibiting the endothelium-dependent effects of acetylcholine.
We did not administer L-arginine to reverse the inhibition of NO synthesis with L-NAME, because a high dose of L-arginine has been reported to produce nonspecific vasodilation16). Instead, D-NAME was used to demonstrate the specificity of inhibition of NO synthesis by L-NAME in this study. 
Summary
The present study has shown that constitutive release of NO from resistance coronary vessels is an important mechanism responsible for regulating myocardial perfusion under normal conditions. Acetylcholine-induced coronary vasodilation is largely due to the release of NO from coronary microvessels. Abnormalities in the endothelial NO systemhave been shown in cardiovascular diseases, including atherosclerosis and hypertension1,2,4). Thus, our findings indicate that impaired NO-mediated coronary resistance adjustments under resting as well as stimulated states can lower the ischemic threshold in these conditions. 
